Meihua Y. Han

Chinese Academy Of Medical Sciences & Peking Union Medical College, No. 151, Malianwa North Road
Haidian, 100193, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Correction to "Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy".

Correction to "Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy".

Journal: Molecular pharmaceutics

Published: June 01, 2026

Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy.

Homologous Tumor Cell-Derived Delivery of Doxorubicin via Liquid Nitrogen-Treated 4T1 Cells for Targeted Breast Cancer Therapy.

Journal: Molecular pharmaceutics

Published: February 19, 2026

Selenization-based nanotechnology improves the hypoglycemic and anti-osteoporotic efficacy of Rehmannia glutinosa polysaccharide.

Selenization-based nanotechnology improves the hypoglycemic and anti-osteoporotic efficacy of Rehmannia glutinosa polysaccharide.

Journal: Food research international (Ottawa, Ont.)

Published: October 08, 2025

The Application of Poly(2-(hydroxymethyl)acrylic Acid as a Functional Nanomaterial to Ensure the Biosafety of Herbal Decoctions.

The Application of Poly(2-(hydroxymethyl)acrylic Acid as a Functional Nanomaterial to Ensure the Biosafety of Herbal Decoctions.

Journal: Molecules (Basel, Switzerland)

Published: September 18, 2025

Corrigendum to "TPGS nanoparticles co-loaded with ABT-737 and R848 for breast cancer therapy" [Biomed. Pharmacother. 177 (2024) 117107].

Corrigendum to "TPGS nanoparticles co-loaded with ABT-737 and R848 for breast cancer therapy" [Biomed. Pharmacother. 177 (2024) 117107].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 20, 2025

Prospects of GPR68 in combined chemo-immunotherapy of tumors.

Prospects of GPR68 in combined chemo-immunotherapy of tumors.

Journal: European journal of pharmacology

Published: June 11, 2025

A MnO2-based tumor-seeking nanoplatform for enhanced chemoimmunotherapy against 4T1 breast cancer.

A MnO2-based tumor-seeking nanoplatform for enhanced chemoimmunotherapy against 4T1 breast cancer.

Journal: Materials today. Bio

Published: March 05, 2025

Self-assembly of paclitaxel derivative and fructose as a potent inducer of immunogenic cell death to enhance cancer immunotherapy.

Self-assembly of paclitaxel derivative and fructose as a potent inducer of immunogenic cell death to enhance cancer immunotherapy.

Journal: Materials today. Bio

Published: January 06, 2025

Anti-hepatoma effect of homologous delivery of doxorubicin by HepG2 cells.

Anti-hepatoma effect of homologous delivery of doxorubicin by HepG2 cells.

Journal: International journal of pharmaceutics

Published: August 08, 2024

TPGS nanoparticles co-loaded with ABT-737 and R848 for breast cancer therapy.

TPGS nanoparticles co-loaded with ABT-737 and R848 for breast cancer therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 17, 2024

Simple preparation and greatly improved oral bioavailability: The supersaturated drug delivery system of quercetin based on PVP K30.

Simple preparation and greatly improved oral bioavailability: The supersaturated drug delivery system of quercetin based on PVP K30.

Journal: Drug delivery and translational research

Published: February 08, 2024

Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment.

Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment.

Journal: International journal of nanomedicine

Published: December 16, 2023

Showing 1-12 of 69

Last Updated: 09/26/2026